Research
Low dose oestrogen combined oral contraception and risk of pulmonary embolism, stroke, and myocardial infarction in five million French women: cohort study
BMJ 2016; 353 doi: https://doi.org/10.1136/bmj.i2002 (Published 10 May 2016) Cite this as: BMJ 2016;353:i2002
Data supplement
HTML Page - index.htslp
Files in this Data Supplement:
- Supplementary material - Web appendix - supplementary material
Related articles
- Editorial Published: 13 August 2009; BMJ 339 doi:10.1136/bmj.b3164
- Research Published: 13 August 2009; BMJ 339 doi:10.1136/bmj.b2890
- Research Published: 13 August 2009; BMJ 339 doi:10.1136/bmj.b2921
- Research Published: 21 April 2011; BMJ 342 doi:10.1136/bmj.d2151
- Research Published: 21 April 2011; BMJ 342 doi:10.1136/bmj.d2139
- Research Published: 26 May 2015; BMJ 350 doi:10.1136/bmj.h2135
- Paper Published: 12 June 1999; BMJ 318 doi:10.1136/bmj.318.7198.1579
- Research Published: 25 October 2011; BMJ 343 doi:10.1136/bmj.d6423
- Research Published: 12 September 2013; BMJ 347 doi:10.1136/bmj.f5298
- Editorial Published: 10 May 2016; BMJ 353 doi:10.1136/bmj.i2544
- Research Published: 03 February 2021; BMJ 372 doi:10.1136/bmj.n37
- Research Published: 12 February 2025; BMJ 388 doi:10.1136/bmj-2024-082801
- Opinion Published: 17 February 2025; BMJ 388 doi:10.1136/bmj.r341
See more
- Patients with asthma or heart disease should avoid incense sticks and other airborne pollutants, says CMOBMJ June 03, 2025, 389 r1146; DOI: https://doi.org/10.1136/bmj.r1146
- Where are we in terms of curing—and treating—cystic fibrosis?BMJ April 22, 2025, 389 r699; DOI: https://doi.org/10.1136/bmj.r699
- Tuberculosis: WHO warns of “crippling breakdowns” in response after funding cutsBMJ March 21, 2025, 388 r577; DOI: https://doi.org/10.1136/bmj.r577
- Mpox in Uganda is now responsible for 40% of Africa’s new casesBMJ March 18, 2025, 388 r548; DOI: https://doi.org/10.1136/bmj.r548
- Respiratory health: Follow guidelines to reduce repeat hospital visits, urge campaignersBMJ March 18, 2025, 388 r545; DOI: https://doi.org/10.1136/bmj.r545
Cited by...
- Research on hormonal contraceptives is needed to monitor their evolving safety profile
- Stroke and myocardial infarction with contemporary hormonal contraception: real-world, nationwide, prospective cohort study
- Effectiveness of BNT162b2, mRNA-1273, and ChAdOx1-S vaccines against severe covid-19 outcomes in a nationwide mass vaccination setting: cohort study
- Use of high dose cyproterone acetate and risk of intracranial meningioma in women: cohort study
- Nicotine-replacement therapy, as a surrogate of smoking, and the risk of hospitalization with Covid-19 and all-cause mortality: a nationwide, observational cohort study in France
- Womens health in The BMJ: a data science history
- Risks of 23 specific malformations associated with prenatal exposure to 10 antiepileptic drugs
- Oral anticoagulation therapy use in patients with atrial fibrillation after the introduction of non-vitamin K antagonist oral anticoagulants: findings from the French healthcare databases, 2011-2016
- FSRH Guideline (January 2019, amended October 2023) Combined Hormonal Contraception
- The French prospective multisite registry on sudden unexpected infant death (OMIN): rationale and study protocol
- Clinical practice guidelines for the care of girls and women with Turner syndrome: proceedings from the 2016 Cincinnati International Turner Syndrome Meeting
- What is the care pathway of patients who undergo thyroid surgery in France and its potential pitfalls? A national cohort
- Hormonal Contraception and Risk of Thromboembolism in Women With Diabetes
- Atherothrombotic non-ST segment elevation myocardial infarction in a 42-year-old white female with no known cardiovascular risk factors
- The vascular risks associated with combined oral contraceptives